pharmaphorum

DECEMBER 16, 2021

According to Abhishek, COVID allowed Wellthy to focus on areas in which it could genuinely have an impact, and the company evolved to become a platform that enables life science, & MedTech companies to build and deploy regulatory compliant digital health solutions. About the author.

Pharma Companies 40

Pharma Companies Cardiology Life Science Marketing 40

XTalks

JANUARY 3, 2025

XTALKS WEBINAR: Environmental Sustainability and the Supply of Medicines for Clinical Trials Live and On-Demand: Thursday, January 16, 2025, at 10am EST (4pm CET/EU-Central) Register for this free webinar to learn how major pharma companies are working towards environmental sustainability and reducing their environmental impact.

FDA Approval 59

FDA Approval Drugs Clinical Trials Clinical Trials 59

XTalks

JULY 10, 2023

We did not get a Class II certification for diabetes only, or orthopedics or cardiology; we got a disease-agnostic certification. Now, as we develop new predictive algorithms, whether that is in diabetes, cardiology, respiratory or oncology, we can bring those algorithms to our platform because it is disease-agnostic.

Life Science 52

Life Science Cardiology Regulation Pharma Companies 52

XTalks

JANUARY 22, 2025

The heart and vascular medication market continues to be a critical focus area for pharma companies, with billions of dollars in sales generated annually. Their widespread adoption is driven by strong clinical evidence, broad FDA-approved indications and continued advancements in treatment protocols.

Sales 104

Sales FDA Approval Drugs Marketing 104